For the Quarter Ending March 2026
Diclofenac Potassium Prices in North America
- In United States, the Diclofenac Potassium Price Index rose quarter-over-quarter in Q1 2026, driven by surging precursor costs.
- The Diclofenac Potassium Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0%.
- A Consumer Price Index increase of 3.3% in March 2026 elevated operational expenses for pharmaceutical manufacturers.
- The Diclofenac Potassium Demand Outlook remained strong in March 2026, supported by retail sales growth of 4.0%.
- Stable unemployment at 4.3% and consumer confidence at 91.8 in March 2026 maintained steady prescription pharmaceutical consumption.
- Industrial production growth of 0.7% in March 2026 constrained capacity for energy-intensive active pharmaceutical ingredient synthesis.
- The Manufacturing Index expanded in March 2026, tightening the availability of shared basic chemicals and packaging materials.
- Benzene and toluene feedstock costs surged in March 2026, impacting the Diclofenac Potassium Price Forecast upward.
Why did the price of Diclofenac Potassium change in March 2026 in North America?
- Upstream crude oil and benzene feedstock costs escalated sharply during March 2026, driving prices upward.
- The Producer Price Index rose 4.0% in March 2026, reflecting elevated chemical precursor and energy costs.
- Resilient retail sales growth of 4.0% in March 2026 sustained strong demand for over-the-counter pharmaceuticals.
Diclofenac Potassium Prices in APAC
- In China, the Diclofenac Potassium Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream feedstock costs.
- Consumer inflation rose 1.0% year-over-year in March 2026, while retail sales growth slowed to 1.7% year-over-year in March 2026.
- The Diclofenac Potassium Production Cost Trend increased as producer prices rose 0.5% year-over-year in March 2026.
- Industrial production grew 5.7% year-over-year in March 2026, and the Manufacturing Index expanded in March 2026.
- The unemployment rate reached 5.4% in March 2026, and consumer confidence stood at 86.0 in Q1 2026.
- The Diclofenac Potassium Demand Outlook softened as pharmaceutical manufacturing investment weakened in January 2026.
- Upstream naphtha feedstock costs surged in Q1 2026, placing upward pressure on benzene and production expenses.
- The Diclofenac Potassium Price Forecast remained elevated as chemical export volumes surged significantly in March 2026.
Why did the price of Diclofenac Potassium change in March 2026 in APAC?
- Upstream naphtha and benzene feedstock costs surged across the broader Asian market in March 2026.
- Producer prices increased 0.5% year-over-year in March 2026, directly elevating upstream chemical precursor manufacturing expenses.
- Chemical export volumes surged in March 2026, tightening domestic availability despite elevated plant operating rates.
Diclofenac Potassium Prices in Europe
- In Germany, the Diclofenac Potassium Price Index fell quarter-over-quarter in Q1 2026, driven by weakened pharmaceutical demand.
- The Diclofenac Potassium Production Cost Trend declined as producer prices fell -0.2% in March 2026.
- Inflation rose 2.7% in March 2026, squeezing purchasing power and impacting the Diclofenac Potassium Demand Outlook.
- Retail sales declined -2.0% in March 2026, reducing consumer purchases of OTC Diclofenac Potassium products.
- The Manufacturing Index contracted in March 2026, reflecting cautious procurement and destocking among pharmaceutical manufacturers.
- Stagnant industrial production at 0.0% in February 2026 stabilized precursor chemical supply for API synthesis.
- A stable 4.0% unemployment rate in March 2026 capped out-of-pocket healthcare spending for prescription NSAIDs.
- Negative consumer confidence at -24.7 in March 2026 suppressed demand for premium topical pain relief gels.
- The Diclofenac Potassium Price Forecast reflected downward pressure during January-March 2026 amid structural industry contraction.
Why did the price of Diclofenac Potassium change in March 2026 in Europe?
- Benzene precursor costs declined in March 2026, reducing synthesis expenses for regional pharmaceutical drug manufacturers.
- Retail sales dropped -2.0% in March 2026, weakening consumer demand for OTC pain relief medications.
- The Manufacturing Index contracted in March 2026, driving inventory destocking and reducing bulk purchasing volumes.
For the Quarter Ending December 2025
Diclofenac Potassium Prices in North America
- In the United States, Diclofenac Potassium Price Index rose in Q4 2025, driven by rising production costs and robust demand.
- Production costs increased in Q4 2025, influenced by a 2.7% year-over-year CPI rise in December 2025.
- The Producer Price Index rose 3.0% year-over-year in November 2025, indicating higher input costs for manufacturers.
- Industrial production expanded 2.0% year-over-year in December 2025, supporting stable chemical supply chains.
- Diclofenac Potassium demand outlook was positive in Q4 2025, supported by a strengthening US pharmaceutical market.
- Retail sales increased 3.3% year-over-year in November 2025, bolstering consumer spending on healthcare products.
- A 4.4% unemployment rate in December 2025 supported consumer income, driving pharmaceutical demand.
- The Diclofenac Potassium Price Index is forecast to remain stable with upward pressure due to sustained demand and elevated input costs.
Why did the price of Diclofenac Potassium change in December 2025 in North America?
- Rising production costs in December 2025, influenced by a 2.7% year-over-year CPI increase, affected prices.
- Robust consumer spending, with 3.3% year-over-year retail sales growth in November 2025, supported demand.
- Ongoing chemical asset shutdowns in Q4 2025 and trade volatility contributed to Diclofenac Potassium supply uncertainties.
Diclofenac Potassium Prices in APAC
- In China, the Diclofenac Potassium Price Index fell quarter-over-quarter in Q4 2025 due to weak domestic demand throughout 2025.
- Diclofenac Potassium production costs declined year-on-year in December 2025, with the Producer Price Index at -1.9%.
- Diclofenac Potassium demand faced headwinds in Q4 2025 from 0.9% retail sales growth and cooled consumer sentiment.
- Industrial production grew 5.2% in December 2025, yet low CPI of 0.8% indicated weak inflationary pressure.
- The Diclofenac Potassium Price Index experienced downward pressure in Q4 2025 from broader deflationary trends.
- Diclofenac Potassium price forecast suggests continued stability or slight declines, influenced by persistent weak domestic demand in 2025.
- Raw material inventories for China's manufacturing industry showed a narrowing decline in December 2025.
- China's Manufacturing Index returned to expansion in December 2025, supported by a stable 5.1% unemployment rate.
Why did the price of Diclofenac Potassium change in December 2025 in APAC?
- Weak consumer demand, with 0.9% retail sales growth and 0.8% CPI in December 2025, dampened prices.
- Producer Price Index declined -1.9% in December 2025, reducing Diclofenac Potassium production costs.
- Overall deflationary pressures, indicated by a -1.9% PPI, influenced Diclofenac Potassium prices downward.
Diclofenac Potassium Prices in Europe
- In Germany, the Diclofenac Potassium Price Index fell in Q4 2025, influenced by declining producer prices.
- Diclofenac Potassium production costs declined in December 2025, as the Producer Price Index fell 2.5%.
- Demand for Diclofenac Potassium faced headwinds in December 2025 due to contracting manufacturing and moderate unemployment.
- Consumer Price Index rose 1.8% in December 2025, indicating moderate inflation impacting purchasing power.
- Germany's pharmaceutical market experienced continued growth in 2025, driven by aging population and chronic diseases.
- Industrial production in Germany expanded 0.8% year-over-year in October 2025, supporting supply chains.
- Retail sales in Germany increased 1.1% year-over-year in November 2025, indicating consumer demand strength.
- Elevated European industrial gas prices in November-December 2025 and increased CO2-eq prices impacted production.
- Monochloroacetic acid (MCA) prices, a key feedstock, stabilized in October 2025 after a prior surge.
Why did the price of Diclofenac Potassium change in December 2025 in Europe?
- Producer prices in Germany declined 2.5% in December 2025, reducing production costs.
- Contracting manufacturing activity and low consumer confidence in December 2025 dampened overall demand.
- Despite retail sales growth in November 2025, elevated energy costs in Q4 2025 pressured margins.
For the Quarter Ending September 2025
North America
- In United States, the Diclofenac Potassium Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
- Production costs increased due to a 2.6% PPI rise in August 2025 and 3.0% CPI in September 2025, impacting expenses.
- Demand for Diclofenac Potassium was supported by a 5.42% increase in retail sales in September 2025, boosting OTC purchases.
- A 4.3% unemployment rate in September 2025, with declining consumer confidence, suggested cautious spending affecting demand.
- North American natural gas demand growth in Q1-Q3 2025 contributed to higher energy feedstock costs for production.
- Industrial supplies and materials imports to the US significantly weakened in August 2025, impacting supply chain stability.
- US pharmaceutical preparations exports notably weakened in August 2025, influencing overall trade flows.
- US industrial production increased by 0.1% in September 2025, suggesting very slow growth in the manufacturing sector.
Why did the price of Diclofenac Potassium change in September 2025 in North America?
- Rising input costs, with PPI up 2.6% in August 2025, elevated Diclofenac Potassium production expenses.
- North American natural gas demand growth in Q1-Q3 2025 raised energy feedstock costs for manufacturing.
- Strong retail sales, up 5.42% in September 2025, supported demand for OTC Diclofenac Potassium.
APAC
- In China, the Diclofenac Potassium Price Index fell quarter-over-quarter in Q3 2025, driven by declining production costs and contracting manufacturing activity.
- Diclofenac Potassium production costs decreased in Q3 2025, influenced by a 2.3% decline in PPI in September 2025.
- Demand for Diclofenac Potassium was supported by a 3.0% rise in retail sales in September 2025, particularly for OTC applications.
- Overall chemical feedstock costs declined in Q3 2025, contributing to lower production expenses for Diclofenac Potassium.
- China's chemical production capacity expanded significantly in Q3 2025, leading to continued overcapacity and supply pressure.
- Pharmaceutical exports from China strengthened in Q3 2025, despite a contracting Manufacturing Index in September 2025.
- Consumer confidence at 89.6 and a stable 5.2% unemployment rate in September 2025 offered mixed demand signals.
- Industrial production grew by 6.5% in September 2025, supporting overall economic stability for Diclofenac Potassium demand.
Why did the price of Diclofenac Potassium change in September 2025 in APAC?
- Declining PPI of -2.3% in September 2025 reduced production costs for Diclofenac Potassium manufacturers.
- Contracting Manufacturing Index in September 2025 and chemical overcapacity created downward price pressure.
- Negative CPI of -0.3% in September 2025 indicated deflation, impacting consumer purchasing power for OTC products.
Europe
- In Germany, the Diclofenac Potassium Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices for chemicals.
- Production costs were positively impacted by a -1.7% PPI year-over-year in September 2025, indicating some cost reductions.
- Despite lower producer prices, the German chemical and pharma industry faced persistently high overall operational costs in Q3 2025.
- Diclofenac Potassium demand was constrained by cautious consumer spending and a stable 6.3% unemployment rate in September 2025.
- The Manufacturing Index contracted in Q3 2025, with industrial production declining 1.0% in September 2025, signaling weaker demand.
- Modest 0.2% year-over-year retail sales growth in September 2025 offered slight support for over-the-counter Diclofenac Potassium.
- Pharmaceutical production increased in July 2025, but the sector faced price and cost pressure in Germany during Q3 2025.
- Capacity utilization in the German chemical industry remained below profitability in Q3 2025, and exports fell significantly.
Why did the price of DICLOFENAC POTASSIUM change in September 2025 in Europe?
- Producer prices for chemicals and pharmaceuticals declined in Q3 2025, reducing manufacturing costs for Diclofenac Potassium.
- Weakening industrial production, down 1.0% in September 2025, and cautious consumer spending dampened overall Diclofenac Potassium demand.
- High operational costs, indicated by 2.4% CPI year-over-year in September 2025, partially offset production cost reductions.
